866-997-4948(US-Canada Toll Free)

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Published By :

GlobalData

Published Date : Jan 2012

Category :

Surgical Equipment

No. of Pages : 90 Pages


The global Continuous Glucose Monitoring (CGM) systems market was valued at $92.2m in 2010, and is forecast to grow to a value of $198m by 2017 at a Compound Annual Growth Rate (CAGR) of 11.6%. The market is forecast to grow due to the increased diabetes patient population across the globe, growing acceptance of CGM systems in low and middle income countries, and an improving reimbursement scenario for CGM systems among private and federal healthcare insurance service providers in the US market.

The US is the Biggest Market for Continuous Glucose Monitoring Systems Market

The CGM systems market is still very much a niche market, with the majority of sales coming from the US, which accounts for 94% of the revenue earned from CGMs. The European market for CGM systems is still in a nascent stage and contributes only 2% towards the global CGM revenues. The remaining market, which consists of the Asia-Pacific region and Brazil, contributes 4% to the global revenues. The main reason for the slow growth rate of the global CGM systems market is the late launch of CGM systems in advanced nations such as Japan and Australia pertaining to regulatory approval, and a slow acceptance of CGM systems in low and middle income nations, such and China and India. The lack of reimbursement and high out-of-pocket cost of CGM systems are also an inhibiting factor for market growth outside the US.

Medtronic was the Leading Player in the Global Global Continuous Glucose Monitoring Systems Market in 2010

Medtronic was the leading player in 2010’s global CGM market, holding a 72% market share. The other players in the CGM market are Dexcom and Abbott; however, as Abbot has withdrawn its CGM product from the US market its share is expected to decrease further. In future, the market is likely to observe a number of new technology-intensive companies launching their own CGM products, either in collaboration with the already established players or on their own. The market may be also consolidated by acquisition of such small technology start-ups by established market players to advance their own R&D.

The market may witness a significant change if any of the existing or new CGM market players are able to develop and launch a diabetes management product based on closed loop technology. This technology, also known as ‘Artificial Pancreas’, is seen as a revolutionary technology with a very promising future in the field of diabetes management. A number of companies, both new and established, are involved in the development of closed loop technology.

GlobalData’s new report, “Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global Continuous Glucose Monitoring (CGM) Systems market. The report provides market landscape, competitive landscape and market trends information on the CGM Systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, China, India, Australia, and Brazil.
  • Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends, market drivers, and restraints within the CGM Systems market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Medtronic, Abbott Laboratories and DexCom.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments that are driving the CGM Systems globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What’s the next big thing in the CGM Systems market landscape? – Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global full- CGM Systems market and the factors shaping it.
Table of Content:

1 Table of Contents 3

1.1 List of Tables 5
1.2 List of Figures 7

2 Introduction and Overview 8
2.1 Introduction 8
2.2 GlobalData Report Guidance 8

3 Disease Overview - Diabetes 9
3.1 Types of Diabetes 9
3.1.1 Type 1 diabetes 9
3.1.2 Type 2 diabetes 9
3.1.3 Gestational diabetes 9
3.2 Epidemiology 9
3.2.1 Prevalence of Diabetes in the US 9
3.2.2 Prevalence of Diabetes in the UK 10
3.2.3 Prevalence of Diabetes in Japan 10
3.2.4 Prevalence of Diabetes in India 10
3.2.5 Prevalence of Diabetes in China 10
3.3 Diagnosis 10
3.3.1 Fasting Plasma Glucose (FPG) Test 10
3.3.2 Oral Glucose Tolerance Test (OGTT) 11
3.3.3 Random Plasma Glucose Test 11

4 Device Overview 12
4.1 Continuous Glucose Monitoring System 12
4.2 Continuous Glucose Monitoring System, Design 12
4.3 Continuous Glucose Monitoring Systems, Shortcomings 12

5 Continuous Glucose Monitoring Systems - Global Market Characterization 13
5.1 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Historic, 2003 - 2010 13
5.2 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Forecast, 2010 - 2017 14
5.3 Continuous Glucose Monitoring Systems Market, Key Trends 15
5.3.1 Alternative Technologies based on Less or Non-Invasive Techniques 15
5.3.2 Companies Identifying Unmet Market Need for Continuous Glucose Monitoring in Hospitals 16
5.3.3 Trend of Integration of the Device Data with Portable Smart Devices 17
5.4 Continuous Glucose Monitoring Systems, Market Dynamics 18
5.4.1 Market Drivers 18
5.4.2 Market Restraints 25

6 Continuous Glucose Monitoring Systems Market, Analysis by Country, Revenue ($m), 2003 - 2017 27
6.1 Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), Historic, 2003 - 2010 27
6.2 Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), Forecast, 2010 - 2017 28
6.3 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($’000), Historic, 2003 - 2010 29
6.4 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($’000), Forecast, 2010 - 2017 30
6.5 Continuous Glucose Monitoring Systems Market, The UK, Revenue ($’000), Historic, 2003 - 2010 31
6.6 Continuous Glucose Monitoring Systems Market, The UK, Revenue ($’000), Forecast, 2010 - 2017 32
6.7 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($’000), Historic, 2003 - 2010 33
6.8 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($’000), Forecast, 2010 - 2017 34
6.9 Continuous Glucose Monitoring Systems Market, France, Revenue ($), Historic, 2003 - 2010 35
6.10 Continuous Glucose Monitoring Systems Market, France, Revenue ($), Forecast, 2010 - 2017 36
6.11 Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), Historic, 2003 - 2010 37
6.12 Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), Forecast, 2010 - 2017 38
6.13 Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), Historic, 2003 - 2010 39
6.14 Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), Forecast, 2010 - 2017 40
6.15 Continuous Glucose Monitoring Systems Market, Japan, Revenue ($’000), Historic, 2010 41
6.16 Continuous Glucose Monitoring Systems Market, Japan, Revenue ($’000), Forecast, 2010 - 2017 42
6.17 Continuous Glucose Monitoring Systems Market, China, Revenue ($’000), Historic, 2004 - 2010 43
6.18 Continuous Glucose Monitoring Systems Market, China, Revenue ($’000), Forecast, 2010 - 2017 44
6.19 Continuous Glucose Monitoring Systems Market, India, Revenue ($’000), Historic, 2007 - 2010 45
6.20 Continuous Glucose Monitoring Systems Market, India, Revenue ($’000), Forecast, 2010 - 2017 46
6.21 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($’000), Historic, 2007 - 2010 47
6.22 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($’000), Forecast, 2010 - 2017 48
6.23 Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($’000), Historic, 2005 - 2010 49
6.24 Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($’000), Forecast, 2010 - 2017 50

7 Continuous Glucose Monitoring Systems Market - Strategic Competitive Assessment 51
7.1 Continuous Glucose Monitoring Systems, Key Market Participants 52
7.1.1 Medtronic Inc. 52
7.1.2 Dexcom 56
7.1.3 Abbott Laboratories 59

8 Continuous Glucose Monitoring Systems - Strategic Pipeline Assessment 61
8.1 Continuous Glucose Monitoring Systems in Clinical Development Stage 62
8.1.1 EyeSense, Blood Glucose Measurement Device, EyeSense GmbH 63
8.1.2 FAS Glucose Monitoring System, BioTex, Inc. 65
8.1.3 GluCath Intravascular Continuous Glucose Monitor, GluMetrics, Inc. 66
8.1.4 5th Generation Short-term Sensor, Dexcom 66
8.1.5 Continuous Glucose Monitor, MicroCHIPS, Inc. 66
8.1.6 Automated Blood Glucose Monitor, Luminous Medical 67
8.1.7 Automated Glucose Monitoring System, Cascade Metrix Inc. 69
8.1.8 CGM Biosensor, Invivosense ASA 70
8.1.9 CGM Sensor, CGM3 70
8.1.10 Continuous Intravascular Glucose Monitoring Device, Technomark Life Sciences Corporation 70
8.1.11 Eirus System, Dipylon Medical AB 72
8.2 Continuous Glucose Monitoring Systems in Approval Phase 73
8.2.1 Enlite Sensor, Medtronic, Inc. 73
8.3 Continuous Glucose Monitoring Systems in Early Development Stage 74
8.3.1 Biologue, ULTRADIAN Diagnostics. 74
8.3.2 Altea MicroPor Laser, GUIDED THERAPEUTICS, INC 75
8.3.3 Closed Loop Continuous Glucose Monitoring System, ConvaTec 75
8.3.4 GlucoChip, PositiveID Corporation 75
8.4 Continuous Glucose Monitoring Systems in Pre Clinical Development Stage 76
8.4.1 Electronic Mosquito, University of Calgary 76
8.4.2 GlucoReader, mobiLIFE 76

9 Continuous Glucose Monitoring Systems Market - Strategic Deals Analysis 77
9.1 Continuous Glucose Monitoring Devices Market, Venture Financing Deals, 2008 - 2011 78
9.2 Continuous Glucose Monitoring Devices Market, Partnerships, 2008 - 2011 80
9.3 Continuous Glucose Monitoring Devices Market, Equity Offering Deals, 2008 - 2011 81
9.4 Continuous Glucose Monitoring Devices Market, Debt Offering Deals,  2008 - 2011 82
9.5 Continuous Glucose Monitoring Devices Market, Acquisitions, 2008 - 2011* 83
9.6 Continuous Glucose Monitoring Devices Market, Asset Transaction Deals, 2008 - 2011* 83
9.7 Key Deals 83
9.7.1 Roche Diagnostics Enters into Research & Development and Distribution Agreement with Dexcom 83
9.7.2 Medtronic Acquires Glucose Monitoring Assets from PreciSense 84
9.7.3 Bayer HealthCare Completes Acquisition of iSense 84
9.7.4 Edwards Lifesciences Enters into an Agreement with Dexcom 84

10 Appendix 86
10.1 Market Definitions 86
10.1.1 Continuous Glucose Monitoring Systems 86
10.2 Acronyms 87
10.3 Research Methodology 88
10.3.1 Secondary Research 88
10.3.2 Primary Research 88
10.3.3 Models 89
10.3.4 Forecasts 89
10.3.5 Expert Panels 89
10.4 GlobalData Consulting 89
10.5 Contact Us 89
10.6 Disclaimer 90
10.7 Sources 90

List of Table


Table 1: Fasting Plasma Glucose Test 10
Table 2: Oral Glucose Tolerance Test 11
Table 3: Oral Glucose Tolerance Test for Gestational Diabetes 11
Table 4: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2003 - 2010 13
Table 5: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2010 - 2017 14
Table 6: Continuous Glucose Monitoring, Alternate Technologies 16
Table 7: Smart Phone Application for Diabetes Management, By Companies, 2011 17
Table 8: Diabetes Prevalence (%) and Patient Population, by Country, 2011 19
Table 9: Increase in Diabetes Patient Population (20-79 years) (%), by Region, 2011 - 2030 20
Table 10: Insulin Pumps, Global, Revenue ($m), 2003 - 2010 22
Table 11: CGM Coverage Policies of Private Insurers, the US, 2011 24
Table 12: Average Selling Price Comparison ($) of Traditional and Continuous Glucose Meters, by Country, 2010 25
Table 13: Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), 2003 - 2010 27
Table 14: Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), 2010 - 2017 28
Table 15: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($’000),  2003 - 2010 29
Table 16: Continuous Glucose Monitoring Devices Systems Market, Canada, Revenue ($’000), 2010 - 2017 30
Table 17: Continuous Glucose Monitoring Systems Market, The UK, Revenue ($’000),  2003 - 2010 31
Table 18: Continuous Glucose Monitoring Systems Market, The UK, Revenue ($’000),  2010 - 2017 32
Table 19: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($’000),  2003 - 2010 33
Table 20: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($’000),  2010 - 2017 34
Table 21: Continuous Glucose Monitoring Systems Market, France, Revenue ($), 2003 - 2010 35
Table 22: Continuous Glucose Monitoring Systems Market, France, Revenue ($), 2010 - 2017 36
Table 23: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), 2003 - 2010 37
Table 24: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), 2010 - 2017 38
Table 25: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), 2003 - 2010 39
Table 26: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), 2010 - 2017 40
Table 27: Continuous Glucose Monitoring Systems Market, Japan, Revenue ($’000), 2010 41
Table 28: Continuous Glucose Monitoring Systems Market, Japan, Revenue ($’000), 2010 - 2017 42
Table 29: Continuous Glucose Monitoring Devices Systems Market, China, Revenue ($’000), 2004 - 2010 43
Table 30: Continuous Glucose Monitoring Systems Market, China, Revenue ($’000), 2010 - 2017 44
Table 31: Continuous Glucose Monitoring Systems Market, India, Revenue ($’000), 2007 - 2010 45
Table 32: Continuous Glucose Monitoring Systems Market, India, Revenue ($’000), 2010 - 2017 46
Table 33: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($’000),  2007 - 2010 47
Table 34: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($’000),  2010 - 2017 48
Table 35: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($’000), 2005 - 2010 49
Table 36: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($’000), 2010 - 2017 50
Table 37: Continuous Glucose Monitoring Systems Market, Global, Company Share (%), Company Revenue ($m), 2010 51
Table 38: Medtronic, Key Products 52
Table 39: Medtronic, Alliances, 2007 - 2011 54
Table 40: Dexcom, Key Products 56
Table 41: Dexcom, Alliances, 2008 - 2011 58
Table 42: Abbott Laboratories, Key Products 59
Table 43: Continuous Glucose Monitoring Systems, Global Pipeline Products, 2011 61
Table 44: List of Continuous Glucose Monitoring Systems in Clinical Development Stage 62
Table 45: EyeSense Blood Glucose Measurement Device, Status 63
Table 46: EyeSense Blood Glucose Measurement Device, Clinical Trial 64
Table 47: FAS Glucose Monitoring System, Status 65
Table 48: FAS Glucose Monitoring System, Clinical Trial 65
Table 49: GluCath Intravascular Continuous Glucose Monitor, Status 66
Table 50: 5th Generation Short-term Sensor, Status 66
Table 51: Continuous Glucose Monitor, Status 67
Table 52: Automated Blood Glucose Monitor, Product Status 67
Table 53: Automated Blood Glucose Monitor, Clinical Trial 68
Table 54: Automated Glucose Monitoring System, Status 69
Table 55: Automated Glucose Monitoring System, Clinical Trial 69
Table 56: CGM Biosensor, Status 70
Table 57: CGM Sensor, Status 70
Table 58: Continuous Intravascular Glucose Monitoring Device, Status 70
Table 59: Continuous Intravascular Glucose Monitoring Device, Clinical Trial 71
Table 60: Eirus System, Status 72
Table 61: List of Continuous Glucose Monitoring Systems in Approval Process 73
Table 62: Enlite Sensor, Status 73
Table 63: List of Continuous Glucose Monitoring Systems in Early Development Stage 74
Table 64: Biologue, Status 74
Table 65: Altea MicroPor Laser, Status 75
Table 66: Closed Loop Continuous Glucose Monitoring System, Status 75
Table 67: Closed Loop Continuous Glucose Monitoring System, Status 75
Table 68: List of Continuous Glucose Monitoring Systems in Pre-Clinical Stage 76
Table 69: Electronic Mosquito, Status 76
Table 70: GlucoReader, Status 76
Table 71: Continuous Glucose Monitoring Systems Market, Deals, 2008-2011* 77
Table 72: Continuous Glucose Monitoring Devices Market, Venture Financing Deals, 2008 - 2011* 78
Table 73: Continuous Glucose Monitoring Devices Market, Partnerships, 2008 - 2011* 80
Table 74: Continuous Glucose Monitoring Devices Market, Equity Offering Deals, 2008 - 2011* 81
Table 75: Continuous Glucose Monitoring Devices Market, Debt Offering Deals, 2008 - 2011* 82
Table 76: Continuous Glucose Monitoring Devices Market, Acquisitions, 2008 - 2011* 83
Table 77: Continuous Glucose Monitoring Devices Market, Asset Transaction Deals, 2008 - 2011* 83

List of Chart


Figure 1: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2003 - 2010 13
Figure 2: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2010 - 2017 14
Figure 3: Continuous Glucose Monitoring Systems, Market Dynamics 18
Figure 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011 18
Figure 5: Insulin Pumps, Global, Revenue ($m), 2003 - 2010 22
Figure 6: Continuous Glucose Monitoring Systems, the US vs. Other Countries, Revenues (% contribution), 2010 23
Figure 7: Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), 2003 - 2010 27
Figure 8: Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), 2010 - 2017 28
Figure 9: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($’000),  2003 - 2010 29
Figure 10: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($’000),  2010 - 2017 30
Figure 11: Continuous Glucose Monitoring Systems Market, The UK, Revenue ($’000),  2003 - 2010 31
Figure 12: Continuous Glucose Monitoring Systems Market, The UK, Revenue ($’000),  2010 - 2017 32
Figure 13: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($’000),  2003 - 2010 33
Figure 14: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($’000),  2010 - 2017 34
Figure 15: Continuous Glucose Monitoring Systems Market, France, Revenue ($), 2003 - 2010 35
Figure 16: Continuous Glucose Monitoring Systems Market, France, Revenue ($), 2010 - 2017 36
Figure 17: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), 2003 - 2010 37
Figure 18: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), 2010 - 2017 38
Figure 19: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), 2003 - 2010 39
Figure 20: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), 2010 - 2017 40
Figure 21: Continuous Glucose Monitoring Systems Market, Japan, Revenue ($’000), 2010 41
Figure 22: Continuous Glucose Monitoring Systems Market, Japan, Revenue ($’000), 2010 - 2017 42
Figure 23: Continuous Glucose Monitoring Systems Market, China, Revenue ($’000), 2004 - 2010 43
Figure 24: Continuous Glucose Monitoring Systems Market, China, Revenue ($’000), 2010 - 2017 44
Figure 25: Continuous Glucose Monitoring Systems Market, India, Revenue ($’000), 2007 - 2010 45
Figure 26: Continuous Glucose Monitoring Systems Market, India, Revenue ($’000), 2010 - 2017 46
Figure 27: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($’000),  2007 - 2010 47
Figure 28: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($’000),  2010 - 2017 48
Figure 29: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($’000), 2005 - 2010 49
Figure 30: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($’000), 2010 - 2017 50
Figure 31: Continuous Glucose Monitoring Systems Market, Global, Company Share (%), 2010 51
Figure 32: Medtronic, SWOT Analysis 53
Figure 33: Dexcom, SWOT Analysis 56
Figure 34: Abbott Laboratories, SWOT Analysis 59
Figure 35: Continuous Glucose Monitoring Systems, Global Pipeline Products, 2011 61
Figure 36: Continuous Glucose Monitoring Systems Market, Deals, 2008-2011* 77

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *